Eliglustat (cerdelga)
Ended Awarded
- Contract number
- 36C26019F0163
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,831
Award facts
- Contract value 100% obligated
- $17,830.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98108, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 36C26019F0163?
36C26019F0163 was awarded to Genzyme Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 11, 2019.
How much is contract 36C26019F0163 worth?
The government has obligated $17,831 on 36C26019F0163.
Is contract 36C26019F0163 an order under another contract?
Yes. 36C26019F0163 is a BPA call under V797P2086D-VA797P16A0017, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019F0163 competed?
The extent of competition for 36C26019F0163 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award